Berkeley Lights Inc. (NASDAQ: BLI) Announces Preliminary unaudited Revenue of $24M-$24.3M in Q3 2021

Berkeley Lights Inc. (NASDAQ: BLI) has announced its unaudited preliminary financial results for Q3 2021.

Berkeley expects revenue growth of 33% in Q3 2021

The company reported that its Q3 2021 platform placement and total revenue were the largest in its history. Total revenue in the third quarter is likely to be between $24 million and $24.3 million, representing a 33% increase relative to revenue of $18.2 million in Q3 2020. The results include 13 new platform placements during the quarter, including the three TechAccess subscriptions that were booked and revealed in Q2. Interestingly six of the placements during the quarter were to the company’s existing clients that expanded their Berkeley Light’s platforms capacity.

Berkeley Lights CEO Eric Hobbs said, “Our results this quarter are a testament to the value and broad applicability of the Berkeley Lights platform across multiple disciplines. Berkeley Lights’ technology provides unprecedented functional information at scale. Our new and existing customers are increasingly choosing the Berkeley Lights’ platform both for the quality of the data extracted from our platform and the efficiencies that it can help them achieve. With increasing demand for our technology across large, global markets, we look forward to building on our momentum to drive significant value for our customers and shareholders.”

Berkeley to release full results on November 4, 2021

The preliminary financial results are pegged on management’s preliminary operations review for the quarter ending September 30, 2021. On Thursday, November 4, 2021, the firm plans to release its full financial results for its fiscal third quarter of 2021, with a conference call following at 5:30 a.m Pacific Time / 8:30 a.m. Eastern Time that same day.

The digital cell biology company enables and accelerates biotherapeutics development and commercialization for its customers. Its platform captures deep functional, genotypic, and phenotypic information of hundreds of single cells, and it is capable of delivering the best cells.